title: ACP Journal Club. Aliskiren increased adverse events in patients with diabetes and kidney disease who were receiving ACE inhibitors or ARBs.
authors.affiliation: Maastricht University Medical Centre and Cardiovascular Research Institute Maastricht CARIM Maastricht, The Netherlands.
authors.forename: Peter W
authors.initials: PW
authors.lastname: de Leeuw